Publications by authors named "Andrew Calabrese"

Claim this Profile
T
The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen.
Jennifer R Riggs, Mark Nagy, Jan Elsner, Paul Erdman, Dan Cashion, Andrew Calabrese

J Med Chem· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rules and stereoelectronic guidelines for the anionic nucleophilic displacement of furanoside and furanose O-sulfonates.
Karl J Hale, Leslie Hough, Soraya Manaviazar, Andrew Calabrese

Org Lett· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update of the rules for pyranoside sulfonate displacement.
Karl J Hale, Leslie Hough, Soraya Manaviazar, Andrew Calabrese

Org Lett· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposing advancement criteria for efficient DMPK triage of new chemical entities.
Ashutosh Kulkarni, Jennifer Riggs, Cindy Phan, April Bai, Andrew Calabrese

Future Med Chem· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead Diversification 2: application to P38, gMTP and lead compounds.
M Abid Masood, Marc Bazin, Mark E Bunnage, Andrew Calabrese, Mark Cox

Bioorg Med Chem Lett· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palladium-mediated annulation of vinyl aziridines with Michael acceptors: stereocontrolled synthesis of substituted pyrrolidines and its application in a formal synthesis of (-)-α-kainic acid.
Martin A Lowe, Mehrnoosh Ostovar, Serena Ferrini, C Chun Chen, Paul G Lawrence, Andrew A Calabrese

Angew Chem Int Ed Engl· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a selective small-molecule melanocortin-4 receptor agonist with efficacy in a pilot study of sexual dysfunction in humans.
Mark I Lansdell, David Hepworth, Andrew Calabrese, Alan D Brown, Julian Blagg

J Med Chem· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triazole oxytocin antagonists: Identification of an aryloxyazetidine replacement for a biaryl substituent.
Alan Brown, T Bruce Brown, Andrew Calabrese, Dave Ellis, Nicholas Puhalo

Bioorg Med Chem Lett· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimising metabolic stability in lipophilic chemical space: the identification of a metabolically stable pyrazolopyrimidine CRF-1 receptor antagonist.
Duncan C Miller, Wolfgang Klute, Andrew Calabrese, Alan D Brown

Bioorg Med Chem Lett· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triazole oxytocin antagonists: identification of aryl ether replacements for a biaryl substituent.
Alan Brown, Lindsay Brown, T Bruce Brown, Andrew Calabrese, Dave Ellis

Bioorg Med Chem Lett· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis